# Relypsa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/relypsa

- Industry: Biotechnology
- Headquarters: Redwood City, US
- Website: www.relypsa.com
- Total disclosed funding: $166M
- Latest round: Series C (Oct 5, 2012)
- Investors on record: 8

## About

Established in 2007, Relypsa is a US based biopharmaceutical company mainly focused on the discovery and development of non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases.

## Funding rounds

- Series C, Oct 5, 2012, $13M — Delphi Ventures, Mediphase Venture Partners, OrbiMed Advisors, Sprout Group, 5AM Ventures, New Leaf Venture Partners, Sibling Capital Ventures
- Series C, Aug 10, 2012, $50M — Delphi Ventures, Mediphase Venture Partners, OrbiMed Advisors, Sprout Group, 5AM Ventures, New Leaf Venture Partners, Sibling Capital Ventures
- Series B, Jul 28, 2011, $0.1M — Delphi Ventures, OrbiMed Advisors, Sprout Group, 5AM Ventures
- Series B, Sep 7, 2010, $70M — Delphi Ventures, Mediphase Venture Partners, OrbiMed Advisors, Sprout Group, 5AM Ventures, New Leaf Venture Partners
- Series A, Mar 11, 2009 — Delphi Ventures, Mediphase Venture Partners, Sprout Group, Presidio Partners, 5AM Ventures, New Leaf Venture Partners
- Series A, Oct 29, 2007, $33M — Delphi Ventures, Mediphase Venture Partners, Sprout Group, Presidio Partners, 5AM Ventures, New Leaf Venture Partners

## Investors

- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series A, Series B, Series C
- Mediphase Venture Partners (https://capitalatlas.ai/funds/mediphase-venture-partners) — Series A, Series B, Series C
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series A, Series B, Series C
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series A
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B, Series C
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series B, Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B, Series C
- Sibling Capital Ventures (https://capitalatlas.ai/funds/sibling-capital-ventures) — Series C